This small-cap stock engaged in providing comprehensive health, accident, and travel insurance solutions, along with telehealth consultations and second medical opinions to its customers, jumped 6 percent after partnering with Sunrisers Hyderabad (SRH) as the Official Health Insurance Partner in the T20 IPL league.
Stock Price Movement
With a market capitalization of Rs. 23,373.33 crores, the share of Star Health and Allied Insurance Company Limited has reached an intraday high of Rs. 415.45 per equity share, rising nearly 6.44 percent from its previous day’s close price of Rs. 397.65. Since then, the stock has retreated and is currently trading at Rs. 397.65 per equity share.
What Happened
Star Health and Allied Insurance has partnered with Sunrisers Hyderabad (SRH) as the official health insurance partner for the 2025 T20 League. This collaboration aims to promote health and wellness through cricket, providing a strong platform to raise awareness. The partnership is a significant step for Star Health Insurance in expanding its presence in the sports sector.
Also read: Auto ancillary stock skyrockets 18% after reporting 52% QoQ growth in net profit; Announces dividend
Product Portfolio
Star Health and Allied Insurance Company offers a range of specialized insurance products, including health insurance plans for individuals, families, and senior citizens, accident insurance, and travel insurance for both domestic and international coverage.
Additionally, the company also provides additional services such as free telehealth consultations and second medical opinions, having completed over 8 lakh consultations.
Business Operation
The company operates through over 850 branches across India, supported by a network of more than 14,000 hospitals and 680,000 agents. It employs over 15,000 personnel and serves individuals, families, and corporates via digital platforms, brokers, and bancassurance partnerships.
Recent quarter results
Star Health and Allied Insurance Company Limited’s revenue has increased from Rs. 3,578 crore in Q3 FY24 to Rs. 4,146 crore in Q3 FY25, which has grown by 15.87 percent. The net profit has decreased by 34.88 percent, from Rs. 290 crore in Q3 FY24 to Rs. 215 crore in Q3 FY25.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
